Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1901 1
1973 1
1974 1
1979 2
1981 1
1982 1
1984 1
1987 1
1990 3
1991 1
1992 2
1994 1
1995 1
1996 3
1997 2
1998 1
2001 2
2002 3
2003 2
2005 2
2006 2
2007 4
2008 6
2009 3
2010 2
2011 2
2012 4
2013 5
2014 8
2015 8
2016 3
2017 11
2018 13
2019 10
2020 4
2021 9
2022 15
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Long GV, Hauschild A, Santinami M, Atkinson V, Mandalà M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Ji R, Zhang P, Mookerjee B, Legos J, Kefford R, Dummer R, Kirkwood JM. Long GV, et al. N Engl J Med. 2017 Nov 9;377(19):1813-1823. doi: 10.1056/NEJMoa1708539. Epub 2017 Sep 10. N Engl J Med. 2017. PMID: 28891408 Free article. Clinical Trial.
Secondary end points included overall survival, distant metastasis-free survival, freedom from relapse, and safety. RESULTS: At a median follow-up of 2.8 years, the estimated 3-year rate of relapse-free survival was 58% in the combination-therapy group and 39% in the place …
Secondary end points included overall survival, distant metastasis-free survival, freedom from relapse, and safety. RESULTS: At a med …
Progress test utopia.
van der Vleuten C, Freeman A, Collares CF. van der Vleuten C, et al. Perspect Med Educ. 2018 Apr;7(2):136-138. doi: 10.1007/s40037-018-0413-1. Perspect Med Educ. 2018. PMID: 29524038 Free PMC article.
This would lead to a significant reduction of cost, an increase in the quality of measurement and phenomenal feedback to learner and school. Progress testing would also provide more freedom and resources for more creative in-school assessment. It would be an educationally …
This would lead to a significant reduction of cost, an increase in the quality of measurement and phenomenal feedback to learner and school. …
Dialogue.
Freeman JW. Freeman JW. S D J Med. 2005 Feb;58(2):51. S D J Med. 2005. PMID: 15756775 No abstract available.
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
J. Voscopoulos, J. Freeman, E. George P251 - Respiratory volume monitoring provides early warning of respiratory depression and can be used to reduce false alarms in non-intubated patients C. J. Voscopoulos, D. Eversole, J. Freeman, E. George P252 - P/i index: a pre …
J. Voscopoulos, J. Freeman, E. George P251 - Respiratory volume monitoring provides early warning of respiratory depression and can b …
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van As N; PACE Trial Investigators. Brand DH, et al. Lancet Oncol. 2019 Nov;20(11):1531-1543. doi: 10.1016/S1470-2045(19)30569-8. Epub 2019 Sep 17. Lancet Oncol. 2019. PMID: 31540791 Free PMC article. Clinical Trial.
Androgen deprivation was not permitted. The primary endpoint of PACE-B is freedom from biochemical or clinical failure. The coprimary outcomes for this acute toxicity substudy were worst grade 2 or more severe Radiation Therapy Oncology Group (RTOG) gastrointestinal or gen …
Androgen deprivation was not permitted. The primary endpoint of PACE-B is freedom from biochemical or clinical failure. The coprimary …
Jose Manuel Rodriguez Delgado, Walter Freeman, and Psychosurgery: A Study in Contrasts.
Fins JJ, Vernaglia JS. Fins JJ, et al. Neuroscientist. 2023 Oct;29(5):518-531. doi: 10.1177/10738584221086603. Epub 2022 Apr 13. Neuroscientist. 2023. PMID: 35414307
Both gained notoriety: Delgado after he appeared on the front page of the New York Times having used his stimoceiver to stop a charging bull in Spain; Freeman as the proponent of lobotomy. Both were the object of critique by the antipsychiatry movement and those who felt t …
Both gained notoriety: Delgado after he appeared on the front page of the New York Times having used his stimoceiver to stop a charging bull …
Prostate mpMRI in the UK: the state of the nation.
Davies C, Castle JT, Stalbow K, Haslam PJ. Davies C, et al. Clin Radiol. 2019 Nov;74(11):894.e11-894.e18. doi: 10.1016/j.crad.2019.09.129. Clin Radiol. 2019. PMID: 31627803 Review.
Prostate Cancer UK (PCUK) and the British Society of Urogenital Radiology submitted a Freedom of Information (FOI) request in 2016 to UK health areas in order to assess the use of mpMRI before biopsy as part of the initial diagnosis pathway. ...
Prostate Cancer UK (PCUK) and the British Society of Urogenital Radiology submitted a Freedom of Information (FOI) request in 2016 to …
A perfect fit.
Stewart M, Brown JB, Freeman T, Weston W, McWilliam C. Stewart M, et al. Can Fam Physician. 2009 Apr;55(4):351. Can Fam Physician. 2009. PMID: 19366937 Free PMC article. No abstract available.
Anticipatory attractors, functional neurochemistry and "Throw & Catch" mechanisms as illustrations of constructivism.
Trofimova I. Trofimova I. Rev Neurosci. 2022 Dec 30;34(7):737-762. doi: 10.1515/revneuro-2022-0120. Print 2023 Oct 26. Rev Neurosci. 2022. PMID: 36584323 Review.
This review explores several rarely discussed examples illustrating constructivism principles, generative and selective features of neuronal regulation of behaviour. First, the review highlights Walter Freeman's experiments and mathematical analysis that uncovered t …
This review explores several rarely discussed examples illustrating constructivism principles, generative and selective features of neuronal …
Migration: a concept analysis from a nursing perspective.
Freeman M, Baumann A, Blythe J, Fisher A, Akhtar-Danesh N. Freeman M, et al. J Adv Nurs. 2012 May;68(5):1176-86. doi: 10.1111/j.1365-2648.2011.05858.x. Epub 2011 Nov 1. J Adv Nurs. 2012. PMID: 22044018 Review.
DISCUSSION: Nurse migration can be defined by five attributes: the motivation and decisions of individuals; external barriers and facilitators; freedom of choice to migrate; freedom to migrate as a human right, and dynamic movement. ...
DISCUSSION: Nurse migration can be defined by five attributes: the motivation and decisions of individuals; external barriers and facilitato …
133 results